Improving the detection, analysis, and reporting of harms in medicines and devices: the 2019 4Es Forum

By |2020-01-20T14:27:18+00:00January 20th, 2020|Categories: Adverse effects - Effets indésirables, Approvals - Homologations, Clinical trials - Essais cliniques, Conflict of interest - Conflits d’intérêts, HPV - HPV/VPH|

From October 7 to 9, 2019, Re-Check’s Catherine Riva participated in the 4Es Forum Improving the detection, analysis and reporting of harms in medicines, a three-day workshop organized by the Centre for Evidence-Based Medicine (CEBM Oxford) and Uppsala Monitoring Center, the WHO Collaborating Centre for International Drug Monitoring. The meeting was held at the Ettore Majorana [...]

Press release – Cochrane’s HPV Vaccines Review

By |2019-06-11T11:40:40+00:00December 10th, 2018|Categories: Approvals - Homologations, Clinical trials - Essais cliniques, Conflict of interest - Conflits d’intérêts, HPV - HPV, HPV vaccine - Vaccination anti-HPV|

The British Medical Journal publication “BMJ Evidence-Based Medicine” unveiled an analysis signed by two investigative journalists and a gynecologist based in Switzerland. The paper brings to light flaws that void the positive conclusions reached by Cochrane. This leaves unanswered the question of HPV vaccine’s efficacy. The BMJ Evidence-Based Medicine article, signed by investigative reporters Catherine Riva [...]

Who’s the bad guy? Become a better health reporter by bringing together ethics and standards of investigative journalism and Evidence-based medicine (EBM)

By |2019-06-11T11:40:40+00:00June 18th, 2018|Categories: Approvals - Homologations, Clinical trials - Essais cliniques, Conflict of interest - Conflits d’intérêts, Training - Enseignement|

Re-Check joined the European Investigative Journalism Conference, that took place in Mechelen, Belgium, In May 2018. We were honored to have the chance to teach one day long to a group of investigative reporters of several countries. Conflicts of interest, debunking flawed health news and how to assess the evidence quality were at the core of [...]

Winding back the harms of too much medicine: Re-Check joined the 5th Preventing Overdiagnosis Conference in Québec City

By |2019-06-11T11:40:40+00:00September 4th, 2017|Categories: Adverse effects - Effets indésirables, Approvals - Homologations, Breast cancer screening - Dépistage du cancer du sein, Clinical trials - Essais cliniques, Endometriosis - Endométriose, HPV - HPV/VPH, HPV vaccine - Vaccination anti-HPV, Overdiagnosis - Surdiagnostic|

Catherine Riva of Re-Check was selected by the organizers of the Conference to present the results of her investigation on the “mammo-business”, an extensive system of business models and careers building grown in Switzerland around mammography screening. Her long-form investigative piece was honored in 2014 with a Media Award of the Swiss Academies of Medical Sciences. [...]

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.
Go to Top